Tracey Doi
Known title: DirectorCIK: 0001527766
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Pentair acquires Taco Group, featured in water market forecast. Pentair has completed the purchase of Taco Group Holdings, expanding its product portfolio in fluid handling. The company is also highlighted in a new market forecast that expects the point‑of‑use water‑treatment sector to grow to $16.38 billion by 2031, indicating potential demand for its solutions. Analysts note the upcoming quarterly earnings and its inclusion among dividend aristocrats, reflecting a focus on stable cash flow and dividend policy.
Transaction History
| DGX | ▲ Buy | Grant | 1,142 | $0 | 5/20/2026 | View on chart |
| PNR | ▲ Buy | Grant | 1,564 | $0 | 1/2/2026 | View on chart |
| PNR | ▼ Sell | Tax Withholding | 688 | $73K | 1/2/2026 | View on chart |
| DGX | ▲ Buy | Grant | 1,203 | $0 | 5/15/2025 | View on chart |
| PNR | ▲ Buy | Grant | 1,643 | $0 | 1/2/2025 | View on chart |
| PNR | ▼ Sell | Tax Withholding | 985 | $99K | 1/2/2025 | View on chart |
| PNR | ▼ Sell | Tax Withholding | 865 | $75K | 8/31/2024 | View on chart |
| DGX | ▲ Buy | Grant | 1,482 | $0 | 5/16/2024 | View on chart |
| PNR | ▲ Buy | Grant | 2,256 | $0 | 1/2/2024 | View on chart |
| PNR | ▲ Buy | Grant | 2,135 | $0 | 8/31/2023 | View on chart |
| DGX | ▲ Buy | Grant | 1,369 | $0 | 5/17/2023 | View on chart |
| DGX | ▲ Buy | Grant | 1,292 | $0 | 5/18/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Quest Diagnostics Preps for Q3 Earnings Amid Dividend Focus
Quest Diagnostics is approaching its third-quarter earnings report, with recent coverage highlighting its position as a dividend-paying stock. The company maintains a 2.10% dividend yield and trades at a 24.7 P/E ratio. Analysts currently set an average price target of $251.40, which sits above the current trading range.
Quest Diagnostics Preps for Q3 Earnings Amid Dividend Focus. Quest Diagnostics is approaching its third-quarter earnings report, with recent coverage highlighting its position as a dividend-paying stock. The company maintains a 2.10% dividend yield and trades at a 24.7 P/E ratio. Analysts currently set an average price target of $251.40, which sits above the current trading range.